In a middle‑aged adult with four weeks of bilateral pedal edema, dyspnea at rest and on lying down with paroxysmal nocturnal dyspnea, a brief episode of dizziness, blood pressure 100/76 mmHg, irregular tachycardia 160 bpm, and clear lung fields, what is the optimal acute management—including rate control, diuresis, anticoagulation, and diagnostic work‑up?

Immediate Management: Acute Heart Failure with Rapid Atrial Fibrillation

This patient requires urgent rate control with intravenous digoxin (preferred given borderline blood pressure 100/76 mmHg), immediate intravenous loop diuretics, and anticoagulation for atrial fibrillation lasting >48 hours, alongside comprehensive diagnostic workup including ECG, echocardiography, BNP/NT-proBNP, and troponin.

Clinical Reasoning

This presentation screams acute decompensated heart failure (ADHF) with new-onset atrial fibrillation with rapid ventricular response (RVR). The constellation of:

• Four weeks of progressive dyspnea at rest, orthopnea, and paroxysmal nocturnal dyspnea
• Bilateral pitting pedal edema
• Irregular tachycardia at 160 bpm
• Clear lung fields (early presentation or right-sided predominance)
• No prior medical care for 15 years

...indicates previously undiagnosed cardiac disease now acutely decompensated, likely triggered or complicated by new atrial fibrillation.

Immediate Diagnostic Workup

Perform these tests immediately 1:

1. 12-lead ECG – Confirm atrial fibrillation, assess for acute coronary syndrome, look for left ventricular hypertrophy or prior silent MI
2. Cardiac troponin – Rule out ACS as precipitant 1
3. BNP or NT-proBNP – Confirm heart failure diagnosis (should be measured in all patients with dyspnea of uncertain etiology) 1
4. Chest X-ray – Assess for pulmonary congestion, cardiomegaly, pleural effusions 1
5. Echocardiography – Determine ejection fraction, assess valvular disease, evaluate chamber sizes and diastolic function 1, 2
6. Basic metabolic panel – Baseline renal function and electrolytes before diuretics 1

Rate Control Strategy

Given the borderline blood pressure (100/76 mmHg), intravenous digoxin is the preferred initial agent 3. Here's why:

• Beta-blockers (metoprolol, esmolol) and calcium channel blockers (diltiazem, verapamil) are first-line for rate control in atrial fibrillation with RVR 3, BUT they require caution with hypotension, LV dysfunction, or heart failure 3
• Digoxin is specifically recommended for patients with hypotension or heart failure 3
• Target heart rate ≤110 bpm 3
• If digoxin alone is insufficient, consider adding low-dose beta-blocker once blood pressure stabilizes
• Amiodarone is an alternative if other measures fail, particularly useful as it may restore sinus rhythm, but requires anticoagulation consideration if AF >48 hours 3

Critical pitfall: Avoid aggressive rate control that drops blood pressure further and compromises end-organ perfusion.

Diuresis Protocol

Start intravenous furosemide immediately – do not delay, as early intervention improves outcomes 1, 4:

• Dose: Since this is new-onset heart failure (no prior diuretic use), start with furosemide 40 mg IV 5, 6
• If patient were already on oral diuretics, the IV dose should equal or exceed the chronic oral daily dose 1
• Monitor closely: Urine output, daily weights (same time each day), fluid intake/output, vital signs 1
• Titrate aggressively based on response – if inadequate diuresis within 6-12 hours, consider 1:
  • Higher loop diuretic doses
  • Adding second diuretic (metolazone, spironolactone, or IV chlorothiazide)
  • Continuous infusion of loop diuretic

Daily monitoring required: Serum electrolytes, BUN, creatinine during active diuresis 1

Anticoagulation Decision

This patient requires anticoagulation – here's the algorithm:

1. Duration assessment: The patient reports symptoms for four weeks, making it highly likely AF has been present >48 hours
2. Stroke risk: Calculate CHA₂DS₂-VASc score:
   • Age, hypertension (likely given presentation), smoking, possible vascular disease = likely ≥2 points
3. Bleeding risk: No contraindications mentioned (no active bleeding, normal platelet count assumed)

Action:

• Start therapeutic anticoagulation immediately with low molecular weight heparin (LMWH) 4
• Transition to oral anticoagulation (DOAC preferred over warfarin in most patients) once stabilized
• If cardioversion is planned, it must occur within 48 hours of AF onset OR after ≥3 weeks of therapeutic anticoagulation OR after transesophageal echo excludes left atrial thrombus 3

Given the 4-week history, cardioversion should NOT be attempted acutely without TEE or 3 weeks of anticoagulation 3.

Additional Acute Management

Oxygen therapy: Titrate to SpO₂ >94% if hypoxemic 1, 7

Consider non-invasive ventilation (BiPAP/CPAP) if respiratory distress develops – recent evidence shows BiPAP improves hemodynamics, reduces sympathetic overactivity, and may facilitate rate control in ADHF with atrial flutter/fibrillation 8

Avoid morphine: Despite historical use, morphine is associated with increased mechanical ventilation, ICU admission, and mortality in ADHF 6

Continue monitoring: Continuous cardiac monitoring for arrhythmias, frequent vital signs, strict intake/output

Identifying Precipitants

Systematically evaluate for common precipitants 1:

• Acute coronary syndrome – troponin, ECG (already ordered)
• Severe hypertension – likely contributor given presentation
• Atrial fibrillation – confirmed, both precipitant and consequence
• Infections – check for pneumonia, urinary tract infection
• Renal failure – check baseline renal function
• Medication/dietary noncompliance – not applicable (no prior diagnosis)
• Thyroid disease – TSH should be checked given new AF 9

Risk Stratification

This patient has multiple high-risk features:

• No medical care for 15 years (undiagnosed/untreated comorbidities)
• Smoking history
• Likely long-standing hypertension
• New atrial fibrillation
• Possible ischemic heart disease (dizziness episode may represent arrhythmia or hypoperfusion)

Cardiac edema carries 25% mortality at 2 years even after adjustment for other factors 10, emphasizing the need for aggressive management and close follow-up.

Disposition and Monitoring

Admit to monitored bed (telemetry or ICU depending on clinical stability):

• Continuous cardiac monitoring
• Hourly vital signs initially
• Strict intake/output measurement
• Daily weights
• Daily electrolytes, BUN, creatinine during active diuresis 1

Reassess at 6-12 hours: If inadequate response to initial diuresis or persistent tachycardia despite rate control, escalate therapy as outlined above.

Long-term Considerations

Once acute decompensation resolves:

• Determine HF phenotype (HFrEF vs HFmrEF vs HFpEF) based on echocardiography 2
• Initiate guideline-directed medical therapy based on ejection fraction
• Address cardiovascular risk factors (smoking cessation, hypertension management)
• Decide on long-term rhythm vs rate control strategy for AF
• Ensure indefinite anticoagulation unless contraindicated
• Close outpatient follow-up given 15-year gap in care

The combination of ADHF with rapid AF in a previously undiagnosed patient requires aggressive, simultaneous management of both conditions while carefully monitoring hemodynamics and avoiding precipitous blood pressure drops.